- Size
-
- Color
-
-
Floor Guide
-
Access Map
-
Search
- HOME
- Legal Authorization of Medical Institutions
- Advanced Medical Care B
Outline
Legal Authorization of Medical Institutions - Advanced Medical Care B
Advanced Medical Care B (As of April 1, 2025)
| Name of Advanced Medical Technologies | Clinical Departments | Date of Approval |
|---|---|---|
| Combined postoperative therapy of internal administration of capecitabine and intravenous administration of oxaliplatin Small bowel adenocarcinoma (limited to Stage I, II, or III cases determined to have been completely removed via visual inspection and pathological findings) |
Gastroenterological Surgery | April 1, 2018 |
| Liver transplant surgery Unresectable hilar bile duct cancer | Pediatric Surgery, Transplantation | September 1, 2022 |
| Living-Donor Liver Transplantation for Unremovable, Metastasized Liver Cancer (Limited to cases involving patients who have undergone colon resection due to metastasis from colon cancer) | Pediatric Surgery, Transplantation | November 1, 2023 |
| Intravenous Cyclophosphamide Treatment | Haematology | April 1, 2024 |
- Outline
-
- Message from the Director
- History
- Faculty and Administrative Officials
- Number of Staff Members
- Postgraduate Clinical Training
- Overview
- Number of Beds
- Number of Patients by Department
- Number of Outpatients and Inpatients by Region
- Budget
- Number of Clinical Examinations
- Number of Surgeries (Including Treatments) and Anesthesia Administrations
- Number of Imaging Diagnosis and Radiation Therapy
- Number of Births
- Number of Prescriptions Written, Cases Observed, and Drugs Administered
- Number of Patient Deaths and Autopsies Performed
- Number of Transfusions Performed
- Peripheral Blood Stem Cell (PBSC) Harvests
- Legal Authorization of Medical Institutions
- The community healthcare partnership